AstraZeneca CEO Pascal Soriot on progress on pancreatic cancer

Pascal Soriot, CEO of AstraZeneca, sits down with CNBC's Meg Tirrell to discuss progress on treatment for pancreatic and breast cancer, as well as growth in demand for the company's cancer treatment drugs.
03:57
Mon, Jun 3 201911:58 AM EDT